Cadent Medical Communications Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Cadent Medical Communications's estimated annual revenue is currently $14M per year.
- Cadent Medical Communications's estimated revenue per employee is $250,000
- Cadent Medical Communications has 56 Employees.
- Cadent Medical Communications grew their employee count by 30% last year.
- Cadent Medical Communications currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Online Review||Pricing|
|MEC North Ameri...||$1030M||4120||N/A||N/A||-||N/A|
What Is Cadent Medical Communications?
inVentiv Health US Medical Communications has just re-launched as Cadent Medical Communications, a Syneos Health company. The return to this brand name is consistent with our heritage since 1996 and the mission of providing high science medical strategy and delivery to pharmaceutical and biotechnology clients. Cadent Medical Communications provides high quality, full service medical education including scientific platforms, publications, speaker bureau, advisory boards, digital, multi-channel planning and execution, thought-leader identification and engagement. By integrating multichannel planning, clinically driven scientific strategy and flawless execution, we help our clients develop a comprehensive and cohesive strategic plan - one that translates the science of medicine and the art of marketing into valuable and actionable, results oriented plans.keywords:N/A
Number of Employees
Employee Growth %
Cadent Medical Communications News
Syneos Health Communications continued to transform its best-in-class ... For the Medical Communications group, Wendy Balter leads Cadent ...
Sandra Horning, the long-time chief medical officer and head of global ... chief corporate affairs and communications officer and Joakim “Kim” ... Cadent – John McBride was named chief financial officer of Cambridge, Mass.
... health policy and communications — will become chief commercial officer. .... Cadent Therapeutics — currently in collaboration with Novartis ...